Publication: Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models
Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models
Date
Date
Date
Citations
Freitag, T. L., Fagerlund, R., Karam, N. L., Leppänen, V.-M., Uğurlu, H., Kant, R., Mäkinen, P., Tawfek, A., Jha, S. K., Strandin, T., Leskinen, K., Hepojoki, J., Kesti, T., Kareinen, L., Kuivanen, S., Koivulehto, E., Sormunen, A., Laidinen, S., Khattab, A., … Saksela, K. (2023). Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models. Vaccine, 41, 3233–3246. https://doi.org/10.1016/j.vaccine.2023.04.020
Abstract
Abstract
Abstract
The ongoing SARS-CoV-2 pandemic is controlled but not halted by public health measures and mass vaccination strategies which have exclusively relied on intramuscular vaccines. Intranasal vaccines can prime or recruit to the respiratory epithelium mucosal immune cells capable of preventing infection. Here we report a comprehensive series of studies on this concept using various mouse models, including HLA class II-humanized transgenic strains. We found that a single intranasal (i.n.) dose of serotype-5 adenoviral vectors expressing eit
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Other Identification Number
Other Identification Number
Other Identification Number
Metrics
Downloads
Views
Citations
Freitag, T. L., Fagerlund, R., Karam, N. L., Leppänen, V.-M., Uğurlu, H., Kant, R., Mäkinen, P., Tawfek, A., Jha, S. K., Strandin, T., Leskinen, K., Hepojoki, J., Kesti, T., Kareinen, L., Kuivanen, S., Koivulehto, E., Sormunen, A., Laidinen, S., Khattab, A., … Saksela, K. (2023). Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models. Vaccine, 41, 3233–3246. https://doi.org/10.1016/j.vaccine.2023.04.020